Literature DB >> 27355747

Therapeutic effects of ellagic acid on L-arginin ınduced acute pancreatitis.

Edip Erdal Yılmaz1, Zübeyir Bozdağ2, Ibrahim Ibiloğlu3, Zülfü Arıkanoğlu4, Ümit Can Yazgan5, Ibrahim Kaplan6, Metehan Gümüş7, Sabri Selçuk Atamanalp8.   

Abstract

PURPOSE: To investigate the therapeutic effects of ellagic acid on L-arginin ınduced acute pancreatitis in rats.
METHODS: Thirty-two were split into four groups. Group 1 (control) rats were performed only laparotomy, no drugs were administered. Group 2 (control+EA) rats were administered 85mg/kg EA orally. Rats were sacrificed by cardiac puncture 24 hours after the administration. Group3 (AP) 24 hours after intraperitoneal L-arginine administration, rats were sacrificed by cardiac puncture. Group 4 (EA)-(AP): 85mg/kg EA was administered orally after the L-arginine administration. 24 hours later, rats were sacrificed by cardiac puncture. Serum TNF-α, IL-1β, IL-6, total oxidative status (TOS), total antioxidant capacity (TAC), amylase levels were determined in all groups.
RESULTS: Group 3 (AP) rats showed significantly raised TOS level as compared to Group1 (control) rats (p<0.001). Following the EA therapy, a decrease in TOS was observed in Group 4 (AP+EA). TAC levels were significantly raised in the Group 4 (AP+EA) compared to the Group 3 (AP) (p=0.003). Group 3 (AP) showed significantly increased TNF-α, IL-1β and IL-6 serum levels as compared to Group 4 (AP+EA). Histopathological changes were supported our result.
CONCLUSION: The healing effects of ellagic acid on inflammatory and oxidative stress were confirmed by histopathological and biochemical evaluations of the pancreatic tissue.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27355747     DOI: 10.1590/S0102-865020160060000006

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  5 in total

1.  The second case of a young man with L-arginine-induced acute pancreatitis.

Authors:  Quentin Binet; Inès Dufour; Emmanuel Agneessens; Jean-Claude Debongnie; Tarik Aouattah; Angélique Covas; Jean-Charles Coche; Xavier De Koninck
Journal:  Clin J Gastroenterol       Date:  2018-04-21

2.  Nilotinib, a tyrosine kinase inhibitor exhibits protection against acute pancreatitis-induced lung and liver damage in rats.

Authors:  Manar A Nader; Heba M Wagih
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

3.  Phytochemicals with protective effects against acute pancreatitis: a review of recent literature.

Authors:  Yao Tang; Mingli Sun; Zhenning Liu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

Review 4.  Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases.

Authors:  Kailin Li; Yao Xiao; Ji Bian; Lin Han; Caian He; Emad El-Omar; Lan Gong; Min Wang
Journal:  Nutrients       Date:  2022-06-20       Impact factor: 6.706

5.  Drug discovery and formulation development for acute pancreatitis.

Authors:  Xue Jiang; Ya-Wen Zheng; Shihui Bao; Hailin Zhang; Ruijie Chen; Qing Yao; Longfa Kou
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.